1098360-87-2

Basic information

• Product Name: 1-(4-BroMophenyl)cyclopropane-1-carbohydrazide
• Synonyms: 1-(4-BroMophenyl)cyclopropane-1-carbohydrazide;1-(4-bromophenyl)cyclopropanecarbohydrazide
• CAS NO: 1098360-87-2
• Molecular Formula: C₁₀H₁₁BrN₂O
• Molecular Weight: 255.11114
• Mol File: 1098360-87-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(4-BroMophenyl)cyclopropane-1-carbohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-BroMophenyl)cyclopropane-1-carbohydrazide(1098360-87-2)
• EPA Substance Registry System: 1-(4-BroMophenyl)cyclopropane-1-carbohydrazide(1098360-87-2)

Safety Data

• Hazardous Substances Data: 1098360-87-2(Hazardous Substances Data)

Usage

General Description

1-(4-Bromophenyl)cyclopropane-1-carbohydrazide is a chemical compound with the molecular formula C10H11BrN2O. It is a hydrazide derivative of cyclopropane and contains a bromophenyl group. This chemical has potential applications in pharmaceuticals and materials science due to its unique structure and functional groups. It may be used in the synthesis of new drugs or as a building block for more complex organic molecules. Additionally, its cyclopropane and bromophenyl moieties make it a valuable starting material for the preparation of novel materials with specific properties. Overall, 1-(4-Bromophenyl)cyclopropane-1-carbohydrazide is a versatile compound with potential uses in various scientific and industrial applications.

Upstream product

• 16532-79-9 4-Bromophenylacetonitrile 
• 345965-52-8 1-(4-bromophenyl)cyclopropanecarboxylic acid 
• 1403396-19-9 tert-butyl 2-{[1-(4-bromophenyl)cyclopropyl]carbonyl}hydrazinecarboxylate 

Downstream Products

• 1403396-61-1 (8R)-3-[1-(4-bromophenyl)cyclopropyl]-8-({[tert-butyl(dimethyl)silyl]oxy}methyl)-8-methyl-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine 
• 1403396-20-2 3-[1-(4-bromophenyl)cyclopropyl]-8-({[tert-butyl(dimethyl)silyl]oxy}methyl)-8-methyl-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine 
• 1403395-12-9 (8R)-4'-{1-[8-(hydroxymethyl)-8-methyl-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepin-3-yl]cyclopropyl}-N,N-dimethylbiphenyl-4-carboxamide 
• 1403396-95-1 (8R)-8-({[tert-butyl(dimethyl)silyl]oxy}methyl)-8-methyl-3-{1-[4-(5-methylpyrazin-2-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine 
• 1403395-92-5 [(8R)-8-methyl-3-{1-[4-(5-methylpyrazin-2-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepin-8-yl]methanol 
• 1403395-90-3 {(8R)-8-methyl-3-{1-[4-(1,3-oxazol-2-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepin-8-yl}methanol 
• 1403396-94-0 (8R)-8-({[tert-butyl(dimethyl)silyl]oxy}methyl)-8-methyl-3-{1-[4-(1,3-oxazol-2-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine 
• 1403395-89-0 (8-methyl-3-{1-[4-(1,3-oxazol-2-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepin-8-yl)methanol 
• 1403396-93-9 8-({[tert-butyl(dimethyl)silyl]oxy}methyl)-8-methyl-3-{1-[4-(1,3-oxazol-2-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine 
• 1403395-88-9 (8-methyl-3-{1-[4-(1H-pyrazol-5-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepin-8-yl)methanol 
• 1403396-92-8 8-({[tert-butyl(dimethyl)silyl]oxy}methyl)-8-methyl-3-{1-[4-(1H-pyrazol-5-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine 
• 1403395-81-2 (8-methyl-3-{1-[4-(3-methyl-1H-pyrazol-4-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepin-8-yl)methanol 
• 1403396-87-1 8-({[tert-butyl(dimethyl)silyl]oxy}methyl)-8-methyl-3-{1-[4-(3-methyl-1H-pyrazol-4-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine 
• 1403395-80-1 (3-{1-[4-(1-isopropyl-1H-pyrazol-4-yl)phenyl]cyclopropyl}-8-methyl-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepin-8-yl)methanol 

Relevant articles and documents

TETRAHYDROTHIAZEPINE DERIVATIVE

The present invention relates to a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof having an excellent effect of inhibiting 11β-hydroxysteroid dehydrogenase type 1: General formula (I) wherein R1 represents a phenyl group that may be substituted with 1 to 5 group(s) independently selected from substituent group A or a heterocyclic group that may be substituted with 1 to 4 group(s) independently selected from substituent group A; R2 independently represents a halogen atom or a C1-C6 alkyl group; n represents an integer of 0 to 2; and substituent group A represents the group consisting of halogen atoms, C1-C6 alkyl groups, and so forth.